GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,710,938 shares of the company's stock after purchasing an additional 290,019 shares during the period. Charles Schwab Investment Management Inc. owned 0.59% of GE HealthCare Technologies worth $254,422,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the stock. Pathway Financial Advisers LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter worth about $25,000. LGT Financial Advisors LLC raised its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC purchased a new stake in GE HealthCare Technologies in the 2nd quarter worth approximately $26,000. Capital Performance Advisors LLP acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Finally, Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC traded up $0.44 during trading hours on Friday, hitting $82.44. 5,934,944 shares of the company's stock traded hands, compared to its average volume of 3,795,040. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The firm's 50-day moving average is $88.35 and its 200-day moving average is $83.60. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55. The company has a market capitalization of $37.66 billion, a PE ratio of 22.65, a PEG ratio of 2.94 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.99 earnings per share. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.29 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies's payout ratio is 3.30%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent analyst reports. Stifel Nicolaus increased their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a report on Monday, September 30th. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. Redburn Atlantic upgraded GE HealthCare Technologies to a "strong-buy" rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a "neutral" rating and a $90.00 price target on the stock. Finally, UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and cut their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.